Who wants the X Prize?

Among the usual suspects, some won't be entering the $10,000 genome contest.

Written byJeffrey M. Perkel
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

When the X Prize Foundation announced on October 4 the Archon X Prize for Genomics - $10 million to the first team to build a device that can sequence 100 human genomes in 10 days with at least 98% coverage and less than one error per 100,000 bases, for under $10,000 per genome - it met both excitement and skepticism.

"This is far beyond what anyone has done at any price," says Chad Nusbaum, codirector of the genome sequencing and analysis program at the Broad Institute of MIT and Harvard. "We've sequenced one genome, but not nearly as well as is being asked by this competition." The Human Genome Project has resulted in just 93% completion, with about one error per 10,000 base pairs, says George Church, professor of genetics at Harvard Medical School. And it doesn't even represent a single individual, adds Nusbaum, "It's a crazy quilt of haplotypes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies